Cure My Disease

Don't miss your cure!

 Log in / Sign up

Immune cells from your tumor could fight cancer again

NCT ID NCT06397963

Recruiting now Disease control Sponsor: Grit Biotechnology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment called GT307, made from a patient's own tumor-fighting immune cells. It is for adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the treatment is safe and to find the best dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR, ADULT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Arion Cancer Center

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Beijing GoBroad hospital

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Affiliated Hospital Of Xuzhou Medical University

    RECRUITING

    Xuzhou, Jiangsu, 221000, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••